Next Article in Journal
A Conserved Carboxylesterase Inhibits Tobacco mosaic virus (TMV) Accumulation in Nicotiana benthamiana Plants
Next Article in Special Issue
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
Previous Article in Journal
Comparison of CRISPR and Marker-Based Methods for the Engineering of Phage T7
Previous Article in Special Issue
Return of the Coronavirus: 2019-nCoV
Open AccessPerspective

Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

1
Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
2
Department of Anthropology, University of Connecticut, Storrs, CT 06269, USA
*
Author to whom correspondence should be addressed.
Viruses 2020, 12(2), 194; https://doi.org/10.3390/v12020194
Received: 2 February 2020 / Revised: 9 February 2020 / Accepted: 9 February 2020 / Published: 10 February 2020
(This article belongs to the Special Issue Pathogenesis of Human and Animal Coronaviruses)
In early December 2019 a cluster of cases of pneumonia of unknown cause was identified in Wuhan, a city of 11 million persons in the People’s Republic of China. Further investigation revealed these cases to result from infection with a newly identified coronavirus, initially termed 2019-nCoV and subsequently SARS-CoV-2. The infection moved rapidly through China, spread to Thailand and Japan, extended into adjacent countries through infected persons travelling by air, eventually reaching multiple countries and continents. Similar to such other coronaviruses as those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS), the new coronavirus was reported to spread via natural aerosols from human-to-human. In the early stages of this epidemic the case fatality rate is estimated to be approximately 2%, with the majority of deaths occurring in special populations. Unfortunately, there is limited experience with coronavirus infections during pregnancy, and it now appears certain that pregnant women have become infected during the present 2019-nCoV epidemic. In order to assess the potential of the Wuhan 2019-nCoV to cause maternal, fetal and neonatal morbidity and other poor obstetrical outcomes, this communication reviews the published data addressing the epidemiological and clinical effects of SARS, MERS, and other coronavirus infections on pregnant women and their infants. Recommendations are also made for the consideration of pregnant women in the design, clinical trials, and implementation of future 2019-nCoV vaccines. View Full-Text
Keywords: coronavirus; Middle East respiratory syndrome; severe acute respiratory syndrome; SARS-CoV; MERS-CoV; Wuhan coronavirus; 2019-nCoV; SARS-CoV-2; COVID-19; pregnancy; maternal mortality; maternal death; pregnancy complications; maternal morbidity; pneumonia; epidemic; emerging infection; China; Wuhan coronavirus outbreak coronavirus; Middle East respiratory syndrome; severe acute respiratory syndrome; SARS-CoV; MERS-CoV; Wuhan coronavirus; 2019-nCoV; SARS-CoV-2; COVID-19; pregnancy; maternal mortality; maternal death; pregnancy complications; maternal morbidity; pneumonia; epidemic; emerging infection; China; Wuhan coronavirus outbreak
Show Figures

Figure 1

MDPI and ACS Style

Schwartz, D.A.; Graham, A.L. Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses 2020, 12, 194.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop